• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

    7/17/24 6:03:31 AM ET
    $ADVM
    $APVO
    $ASML
    $ASST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    Shares of Bloom Energy Corporation (NYSE:BE) rose sharply in today's pre-market trading after the company announced a strategic partnership with CoreWeave.

    Bloom Energy said it entered into a partnership to deploy its proprietary fuel cells to generate on-site power for CoreWeave at a high-performance data center in Illinois.

    Bloom Energy shares jumped 12.1% to $16.90 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Shimmick Corporation (NASDAQ:SHIM) gained 53% to $3.09 in pre-market trading after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares rose 39.3% to $0.46 in pre-market trading after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.
    • MicroAlgo Inc. (NASDAQ:MLGO) shares rose 26.1% to $3.58 in pre-market trading after declining around 14% on Tuesday.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) rose 16.1% to $0.2916 in pre-market trading. Conduit Pharmaceuticals shares gained around 5% on Tuesday after the company announced it received patent approval for its lead asset targeting autoimmune diseases..
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares gained 15.5% to $10.31 in pre-market trading. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.
    • GitLab Inc. (NASDAQ:GTLB) gained 13.9% to $57.71 in pre-market trading after Reuters reported that the company is exploring a sale.
    • Asset Entities Inc. (NASDAQ:ASST) shares climbed 12.6% to $1.77 in pre-market trading.
    • Immersion Corporation (NASDAQ:IMMR) shares surged 12.4% to $13.69 in pre-market trading after gaining over 5% on Tuesday.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares gained 7.7% to $0.21 in pre-market trading.

    Losers

    • Cineverse Corp (NASDAQ:CNVS) shares fell 15.6% to $0.75 in pre-market trading.
    • Logistic Properties of the Americas (NYSE:LPA) shares fell 15.2% to $22.04 in pre-market trading after jumping 69% on Tuesday.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 15.2% to $1.28 in pre-market trading after jumping 41% on Tuesday.
    • Five Below, Inc. (NASDAQ:FIVE) shares declined 14.7% to $87.00 in pre-market trading after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.
    • Safe and Green Development Corporation (NASDAQ:SGD) shares dipped 11% to $0.3642 in pre-market trading.
    • Silo Pharma, Inc. (NASDAQ:SILO) shares fell 9.2% to $2.17 in pre-market trading. Silo Pharma shares jumped 123% on Tuesday after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer’s drug.
    • Eightco Holdings Inc. (NASDAQ:OCTO) shares fell 8.7% to $0.48 in pre-market trading. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.
    • Cerus Corporation (NASDAQ:CERS) fell 8.4% to $2.19 in pre-market trading. On July 2, Cerus announced the appointment of Dean Gregory to its Board of Directors.
    • Siebert Financial Corp. (NASDAQ:SIEB) fell 6.8% to $1.77 in pre-market trading after gaining over 9% on Tuesday.
    • ASML Holding N.V.  (NASDAQ:ASML) shares declined 6.8% to $995.90 in pre-market trading. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.

    Now Read This:

    • Jim Cramer Says If You Sell This Chinese EV Stock Now, ‘Some Clown’ Will Be ‘Real Positive About It,’ Wait Until ‘All That Stuff Happens’
    Get the next $ADVM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $APVO
    $ASML
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    Five Below Inc.
    $FIVE
    9/17/2025$160.00Mkt Perform
    Bernstein
    GitLab Inc.
    $GTLB
    9/11/2025$70.00Buy
    Guggenheim
    ASML Holding N.V. New York Registry Shares
    $ASML
    9/5/2025Neutral → Buy
    UBS
    Five Below Inc.
    $FIVE
    8/28/2025$170.00Market Perform → Outperform
    Telsey Advisory Group
    GitLab Inc.
    $GTLB
    8/22/2025$50.00Neutral
    DA Davidson
    Five Below Inc.
    $FIVE
    8/22/2025$128.00 → $144.00Market Perform
    Telsey Advisory Group
    Five Below Inc.
    $FIVE
    8/12/2025$165.00Hold → Buy
    Loop Capital
    ASML Holding N.V. New York Registry Shares
    $ASML
    7/24/2025Neutral → Buy
    New Street
    More analyst ratings

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO O'Donnell Kevin J bought $250,000 worth of shares (171,233 units at $1.46) and was granted 400,000 shares, increasing direct ownership by 1,987% to 599,985 units (SEC Form 4)

    4 - Eightco Holdings Inc. (0001892492) (Issuer)

    9/11/25 8:07:01 AM ET
    $OCTO

    Director Jennings Frank D bought $200,000 worth of shares (136,986 units at $1.46), increasing direct ownership by 796% to 154,189 units (SEC Form 4)

    4 - Eightco Holdings Inc. (0001892492) (Issuer)

    9/10/25 3:59:46 PM ET
    $OCTO

    Director Caiano Nicola Paul was granted 2,960 shares and bought $500,000 worth of shares (342,466 units at $1.46), increasing direct ownership by 7,105% to 350,288 units (SEC Form 4)

    4 - Eightco Holdings Inc. (0001892492) (Issuer)

    9/10/25 3:58:39 PM ET
    $OCTO

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Blasing Karen sold $162,774 worth of shares (3,250 units at $50.08), decreasing direct ownership by 3% to 100,639 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    9/17/25 6:43:48 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Director Sijbrandij Sytse converted options into 108,600 shares and sold $5,444,696 worth of shares (108,600 units at $50.14) (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    9/17/25 6:40:11 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Staples William covered exercise/tax liability with 10,515 shares, decreasing direct ownership by 3% to 352,909 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    9/17/25 6:23:59 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GitLab Named a Leader in the 2025 Gartner® Magic Quadrant™ for AI Code Assistants

    GitLab was recognized for its execution and vision. All Remote - GitLab Inc. (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today announced it was named a Leader in the 2025 Gartner Magic Quadrant for AI Code Assistants for the second consecutive year. The Magic Quadrant, which evaluated 14 vendors, recognized GitLab as a leader based on "Completeness of Vision" and "Ability to Execute." According to Gartner, "AI code assistants enhance software developers' experience by boosting their efficiency, accelerating application development, minimizing cognitive overload, amplifying their problem-solving skills, enabling faster learning, fostering creativity and maintai

    9/17/25 11:58:00 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    CDT Executes Cryptocurrency Treasury Reserve Strategy

    NAPLES, Fla. And CAMBRIDGE, United Kingdom, Sept. 17, 2025 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced the strategic acquisition of 8.65252366 Bitcoin ("BTC") for an aggregate purchase price of $1,000,000 (inclusive of fees and expenses), at an average acquisition price of $115,285 per BTC. By incorporating Bitcoin into its treasury reserve strategy, CDT aims to strengthen its financial position and reinforce balance sheet resilience, while aligning with the accelerating institutional adoption of digital assets within a regulatory environment that is progressively enabling broader acceptance. "We are pleased to execute the definit

    9/17/25 8:30:00 AM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The Toxic Avenger Brings Radioactive Realness Home; with Dates Announced for Digital and Physical Releases

    The Critically Acclaimed, Fan-Favorite Action-Comedy, Which Garnered an 86% Rotten Tomatoes Score, is Now Available for Digital and Physical Pre-Order LOS ANGELES, Sept. 16, 2025 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, has announced today that The Toxic Avenger will be available on digital EST/TVOD September 30, 2025, followed by a physical release on October 28, 2025. The Toxic Avenger comes home after an overwhelming critical reception which praised director Macon Blair's execution along with strong performances from the all-star cas

    9/16/25 11:00:00 AM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ADVM
    $APVO
    $ASML
    $ASST
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Aptevo Therapeutics Inc.

    SCHEDULE 13G - Aptevo Therapeutics Inc. (0001671584) (Subject)

    9/17/25 5:26:05 PM ET
    $APVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Eightco Holdings Inc.

    SCHEDULE 13G - Eightco Holdings Inc. (0001892492) (Subject)

    9/16/25 9:35:45 PM ET
    $OCTO

    Aptevo Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Aptevo Therapeutics Inc. (0001671584) (Filer)

    9/16/25 5:07:43 PM ET
    $APVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $APVO
    $ASML
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bernstein initiated coverage on Five Below with a new price target

    Bernstein initiated coverage of Five Below with a rating of Mkt Perform and set a new price target of $160.00

    9/17/25 8:02:16 AM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Guggenheim initiated coverage on GitLab with a new price target

    Guggenheim initiated coverage of GitLab with a rating of Buy and set a new price target of $70.00

    9/11/25 8:44:51 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    ASML upgraded by UBS

    UBS upgraded ASML from Neutral to Buy

    9/5/25 7:55:15 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Financials

    Live finance-specific insights

    View All

    GitLab Reports Second Quarter Fiscal Year 2026 Financial Results

    Company Announces CFO Transition Second Quarter Fiscal Year 2026 Highlights: Total revenue of $236.0 million, up 29% year-over-year GAAP operating margin of (8)%; non-GAAP operating margin of 17% Operating cash flow of $49.4 million and non-GAAP adjusted free cash flow of $46.5 million All-Remote-GitLab Inc. (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today reported financial results for its second quarter fiscal year of 2026, ended July 31, 2025. "This quarter's results demonstrate the strength of GitLab's AI-native DevSecOps platform as we continue to drive customer-focused innovation," said Bill Staples, GitLab chief executive officer. "GitLab D

    9/3/25 4:05:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Five Below, Inc. Announces Second Quarter Fiscal 2025 Financial Results

    Q2 Net Sales Increase of 23.7% to $1.0 Billion; Comparable Sales Increase of 12.4% Q2 GAAP Diluted EPS of $0.77, Q2 Adjusted Diluted EPS of $0.81 Increases Full Year 2025 Sales and EPS Guidance PHILADELPHIA, PA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ:FIVE) today announced financial results for the second quarter and year to date period ended August 2, 2025. For the second quarter ended August 2, 2025: Net sales increased by 23.7% to $1,026.8 million from $830.1 million in the second quarter of fiscal 2024; comparable sales increased by 12.4%.The Company opened 32 net new stores and ended the quarter with 1,858 stores in 44 states. This represents an increase in sto

    8/27/25 4:01:00 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    GitLab To Announce Second Quarter Fiscal 2026 Financial Results

    All Remote - GitLab Inc., (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today announced that it will report its financial results for the second quarter of fiscal year 2026, which ended July 31, 2025, after U.S. markets close on Wednesday, September 3, 2025. Management will host a conference call and webcast on the same day to discuss the company's financial results at 4:30 p.m. ET / 1:30 p.m. PT. GitLab Second Quarter Fiscal 2026 Financial Results Conference Call and Webcast When: Wednesday, September 3, 2025 Time: 4:30 p.m. ET / 1:30 p.m. PT Earnings Call Registration Replay: A webcast replay of the conference call will be available on the investor relat

    8/20/25 4:05:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    Strive Announces Acquisition of MSTR True North Inc. Appoints Jeff Walton as Chief Risk Officer & CEO of True North

    Dallas, TX, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. announces a strategic acquisition of MSTR True North Inc. (True North) in a de minimis cash transaction. True North is cash flow positive and the transaction synergies are expected to allow enhanced platform expansion without additional cost. This move cements Strive's position at the forefront of Bitcoin advocacy in the new frontier of Digital Capital and Digital Credit. As part of the acquisition, Strive has appointed True North founder Jeff Walton as Chief Executive Officer of True North and Chief Risk Officer of Strive.  True North member Ben Werkman will continue to serve on Strive's board of directors. This transaction als

    9/16/25 7:15:00 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Siebert Financial Launches Digital Assets Research, Hiring Brian P. Vieten as Research Analyst

    NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Muriel Siebert & Co., LLC (Siebert), a subsidiary of Siebert Financial Corp. (NASDAQ:SIEB), today announced the launch of Digital Assets Research within its Capital Markets division and the appointment of Brian P. Vieten as Research Analyst. The group will publish institutional-grade research on cryptocurrency, blockchain infrastructure, Web3 applications, and public companies with material exposure to digital assets. This expands the firm's research footprint and strengthens support for clients across Capital Markets and Investment Banking.  "Client demand for rigorous digital-asset research is rising fast. Brian brings proven equity research

    9/10/25 8:00:00 AM ET
    $SIEB
    Investment Bankers/Brokers/Service
    Finance

    Siebert Financial Appoints Daniel M. Ondeck as Head of Institutional Sales

    MIAMI and NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Siebert Financial Corp. (NASDAQ:SIEB) announced that Daniel M. Ondeck has joined the firm as Head of Institutional Sales. Based in Washington, D.C., he will lead institutional client coverage and distribution across sector verticals and work closely with Siebert's investment bankers on origination and execution. Mr. Ondeck brings more than two decades of experience in institutional sales and capital markets. He began his career as an infantry Captain in the United States Marine Corps and holds a B.A. from Denison University. He later served in senior sales roles at FBR Capital Markets and B. Riley Financial. At Siebert, Mr. Ondeck wi

    9/4/25 8:00:00 AM ET
    $SIEB
    Investment Bankers/Brokers/Service
    Finance

    $ADVM
    $APVO
    $ASML
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by CERo Therapeutics Holdings Inc.

    SC 13G/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:06:55 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:01:41 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care